Abstract |
In a three-year pilot study on 52 women with severe postmenopausal osteoporosis, treatment with etidronate followed by calcium and vitamin D (ECaD) was compared to etidronate followed by monofluorophosphate, calcium and vitamin D (EFCaD). BMD in lumbar spine, total hip and femoral neck increased significantly more with EFCaD than with ECaD. Pain-mobility score decreased significantly more with EFCaD than with ECaD (p=0.006). New vertebral fractures occurred in three patients under EFCaD (12%) and in nine under ECaD (35%), (p=0.048). Three patients under EFCaD (12%) and 15 under ECaD (58%) did not respond to therapy (p of difference=0.001). Mild or moderate adverse reactions were reported by 25 patients, with no significant difference between the two groups. The pilot study suggests that etidronate, sequentially followed by monofluorophosphate, could be a safe, effective and relatively inexpensive therapy in severe postmenopausal osteoporosis.
|
Authors | J D Ringe, A Dorst, H Faber, C Kipshoven, L C Rovati, I Setnikar |
Journal | Rheumatology international
(Rheumatol Int)
Vol. 25
Issue 4
Pg. 296-300
(May 2005)
ISSN: 0172-8172 [Print] Germany |
PMID | 15770482
(Publication Type: Clinical Trial, Comparative Study, Journal Article)
|
Chemical References |
- Phosphates
- Vitamin D
- fluorophosphate
- Etidronic Acid
- Fluorides
- Calcium
|
Topics |
- Absorptiometry, Photon
- Aged
- Bone Density
(drug effects)
- Bone and Bones
(diagnostic imaging, metabolism)
- Calcaneus
(diagnostic imaging, drug effects, physiopathology)
- Calcium
(administration & dosage)
- Dietary Supplements
- Drug Therapy, Combination
- Etidronic Acid
(therapeutic use)
- Female
- Fluorides
(therapeutic use)
- Fractures, Spontaneous
(prevention & control)
- Humans
- Osteoporosis, Postmenopausal
(metabolism, physiopathology, therapy)
- Pain
(physiopathology, prevention & control)
- Phosphates
(therapeutic use)
- Pilot Projects
- Range of Motion, Articular
(drug effects)
- Spinal Fractures
(diagnostic imaging, prevention & control)
- Treatment Outcome
- Ultrasonography
- Vitamin D
(administration & dosage)
|